Table 3 Incidence and risk of psoriasis among diabetic patients with or without DR and ESRD.
From: Psoriasis risk in patients with diabetic retinopathy: A nationwide population-based study
| Ā | Psoriasis | Person-years | Psoriasis incidence (per 1000 person-years) | Model 1 HR (95% CI) | Model 2 HR (95% CI) | Model 3 HR (95% CI) |
|---|---|---|---|---|---|---|
Group | ||||||
Non-ESRD | 43514 | 10146096.17 | 4.29 | 1 (reference) | 1 (reference) | 1 (reference) |
ESRD | 278 | 23991.82 | 11.59 | 2.66 (2.36, 2.99) | 2.59 (2.30, 2.91) | 2.59 (2.30, 2.91) |
Group | ||||||
Non-DR and Non-ESRD | 38286 | 9154365.31 | 4.18 | 1 (reference) | 1 (reference) | 1 (reference) |
Non-DR and ESRD | 164 | 15307.50 | 10.71 | Ā | 2.47 (2.12, 2.88) | 2.47 (2.11, 2.88) |
DR and Non-ESRD | 5228 | 991730.87 | 5.27 | Ā | 1.22 (1.19, 1.26) | 1.22 (1.19, 1.26) |
DR and ESRD | 114 | 8684.32 | 13.13 | Ā | 2.98 (2.48, 3.59) | 2.99 (2.49, 3.59) |